Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane

Canadian Journal of Ophthalmology

Volumn 44, Issue 5, 2009, Pages 615-616

  Raffa, Lina ^a   Bawazeer, Ahmed ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; CYCLOPLEGIC AGENT; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; VASCULOTROPIN;

ADOLESCENT; BLURRED VISION; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; FLUORESCENCE ANGIOGRAPHY; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; OPTICAL COHERENCE TOMOGRAPHY; REMISSION; REPEATED DRUG DOSE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

EID: 70349464830     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i09-144     Document Type: Letter

References (5)

1. Foster CS, Vitale AT. Diagnosis and Treatment of Uveitis. Philadelphia, Penn.: W.B. Saunders Company; 2002.
2. LiesegangTJ. Vogt Koyanagi Harada. Basic and Clinical Science Course (BCSC) Section 9: Intraocular Inflammation and Uveitis. American Academy of Ophthalmology. 2008:209-221
3. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1994;112:462-464
4. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-1396 (Pubitemid 24319287)
5. Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006;142:1-9. (Pubitemid 43946791)